List of insiders holdings for CRESCENT BIOPHARMA INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | BARRIS PETER J 10% Owner |
2018-05-11 17:01:54 | 0 9,089,041 |
9,089,041 | Form 4 |
| 2 | Invus Public Equities L.P. Artal International S.C.A. Artal International Management S.A. Artal Group S.A. Westend S.A. Wittouck Amaury Stichting Administratiekantoor Westend Invus Public Equities Advisors LLC 10% Owner |
2024-02-09 17:03:53 | 8,589,064 0 |
8,589,064 | Form 13G |
| 3 | NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd BASKETT FOREST DRANT RYAN D KERINS PATRICK J KOLLURI KRISHNA KITTU MOTT DAVID M Viswanathan Ravi Weller Harry R 10% Owner |
2014-01-15 17:14:28 | 4,093,377 0 |
4,093,377 | Form 4 |
| 4 | Sanofi 10% Owner |
2013-11-07 15:29:17 | 0 2,387,250 |
2,387,250 | Form 3 |
| 5 | SANDELL SCOTT D 10% Owner |
2023-01-27 17:15:50 | 0 2,237,196 |
2,237,196 | Form 4 |
| 6 | NEW ENTERPRISE ASSOCIATES 10 L P NEA PARTNERS 10 L P 10% Owner |
2024-05-08 17:06:54 | 2,181,892 0 |
2,181,892 | Form 13D |
| 7 | Invus Public Equities L.P. Invus Public Equities Advisors LLC Siren L.L.C. Invus Global Management LLC DEBBANE RAYMOND 10% Owner |
2024-11-12 16:30:27 | 1,965,114 0 |
1,965,114 | Form 13G |
| 8 | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N 10% Owner |
2025-06-17 18:53:03 | 1,919,944 0 |
1,919,944 | Form 4 |
| 9 | Brumm Joshua T Chief Executive Officer |
2025-06-23 18:26:43 | 1,073,600 0 |
1,073,600 | Form 3 |
| 10 | Semerjian Harout Chief Executive Officer |
2024-01-17 16:05:25 | 695,000 0 |
695,000 | Form 4 |
| 11 | Rock Edwin Chief Medical Officer |
2024-06-24 16:29:48 | 680,403 0 |
680,403 | Form 4 |
| 12 | McNeill Jonathan See Remarks |
2025-06-23 18:27:24 | 536,800 0 |
536,800 | Form 3 |
| 13 | Gust William M. Director |
2014-01-15 16:58:23 | 0 409,947 |
409,947 | Form 4 |
| 14 | Magnani John L. SVP of Research, CSO |
2022-11-14 16:11:48 | 366,078 4,845 |
370,923 | Form 4 |
| 15 | Im Ellie Eunkyung Chief Medical Officer |
2025-06-30 16:21:21 | 257,822 0 |
257,822 | Form 3 |
| 16 | Thackray Helen M. SVP Clinical Development, CMO |
2021-01-22 16:05:00 | 252,115 0 |
252,115 | Form 4 |
| 17 | Rath Chinmaya SVP and Chief Business Officer |
2024-01-17 16:05:15 | 250,000 0 |
250,000 | Form 4 |
| 18 | Johnson Bruce S SVP & Chief Commercial Officer |
2024-01-17 16:05:28 | 250,000 0 |
250,000 | Form 4 |
| 19 | Scalzo Richard William Chief Financial Officer |
2025-06-23 18:28:16 | 234,383 0 |
234,383 | Form 3 |
| 20 | Feldman Eric Jay Chief Medical Officer |
2021-03-08 16:14:39 | 210,498 0 |
210,498 | Form 3 |
| 21 | Doughty Christopher Grant Chief Business Officer |
2025-06-23 18:29:03 | 192,262 0 |
192,262 | Form 3 |
| 22 | Pinkas Jan Chief Scientific Officer |
2025-07-16 19:11:26 | 142,474 0 |
142,474 | Form 4 |
| 23 | Bispham Barbara Harlin See Remarks |
2025-06-30 16:16:25 | 106,235 0 |
106,235 | Form 3 |
| 24 | Lynch Ryan See Remarks |
2025-06-23 18:29:48 | 105,706 0 |
105,706 | Form 3 |
| 25 | Hahn Brian M. SVP Finance, CFO |
2024-06-20 16:15:39 | 70,643 0 |
70,643 | Form 4 |
| 26 | Goldberg Mark Alan Director |
2024-05-01 16:30:04 | 40,000 0 |
40,000 | Form 4 |
| 27 | Koenig Scott Director |
2024-05-01 16:30:48 | 40,000 0 |
40,000 | Form 4 |
| 28 | King Rachel K. Director |
2024-05-01 16:27:06 | 40,000 0 |
40,000 | Form 4 |
| 29 | Andrews Patricia S Director |
2024-05-01 16:26:00 | 40,000 0 |
40,000 | Form 4 |
| 30 | Jackson Scott Thomas Director |
2024-05-01 16:25:19 | 40,000 0 |
40,000 | Form 4 |
| 31 | JUNIUS DANIEL M Director |
2024-05-01 16:24:33 | 40,000 0 |
40,000 | Form 4 |
| 32 | PEARSON TIMOTHY R Director |
2024-05-01 16:29:10 | 40,000 0 |
40,000 | Form 4 |
| 33 | Girard Armand SVP, Chief Business Officer |
2022-11-14 16:04:18 | 29,161 0 |
29,161 | Form 4 |
| 34 | HENOS MICHAEL A Director |
2015-08-11 16:47:00 | 11,000 0 |
11,000 | Form 4 |
| 35 | TOP FRANKLIN H JR Director |
2016-05-19 16:14:09 | 11,000 0 |
11,000 | Form 4 |
| 36 | BARRETT M JAMES Director 10% Owner |
2018-05-21 16:26:52 | 11,000 0 |
11,000 | Form 4 |
| 37 | Balcom Alexandra Director |
2025-06-23 18:43:51 | 9,023 0 |
9,023 | Form 4 |
| 38 | Violin Jonathan Director |
2025-06-23 18:46:20 | 9,023 0 |
9,023 | Form 4 |
| 39 | Fairmount Funds Management LLC Fairmount Healthcare Fund II L.P. Kiselak Tomas Harwin Peter Evan Director 10% Owner |
2025-06-23 18:48:57 | 0 9,023 |
9,023 | Form 4 |
| 40 | Moran Susan Director |
2025-06-23 18:51:54 | 9,023 0 |
9,023 | Form 4 |
| 41 | Lubner David Charles Director |
2025-06-23 18:41:28 | 9,023 0 |
9,023 | Form 4 |
| 42 | Baldwin John J. Director |
2016-07-01 11:43:16 | 1,210 0 |
1,210 | Form 4 |